| Names | |
|---|---|
| Preferred IUPAC name | 2-Methyl-1,2-thiazol-3(2H)-one |
| Other names | 2-Methyl-4-isothiazolin-3-one MI MIT Methylisothiazoline Kathon RO 09-1008 Proxel Acticide MBI Microcare MIT |
| Pronunciation | /ˌmɛθ.ɪl.aɪ.soʊˌθaɪ.əˈzɒl.ɪˌnoʊn/ |
| Identifiers | |
| CAS Number | 2682-20-4 |
| Beilstein Reference | 635675 |
| ChEBI | CHEBI:77831 |
| ChEMBL | CHEMBL1377 |
| ChemSpider | 56461 |
| DrugBank | DB11361 |
| ECHA InfoCard | DTXSID5048755 |
| EC Number | 220-239-6 |
| Gmelin Reference | Gmelin Reference: "104032 |
| KEGG | C18670 |
| MeSH | D000070246 |
| PubChem CID | 40941 |
| RTECS number | GV7090000 |
| UNII | GYL317M823 |
| UN number | UN3438 |
| Properties | |
| Chemical formula | C4H5NOS |
| Molar mass | 115.16 g/mol |
| Appearance | Colorless to pale yellow liquid |
| Odor | Faint medicinal odor |
| Density | 1.02 g/cm³ |
| Solubility in water | Soluble |
| log P | -0.486 |
| Vapor pressure | 0.62 mmHg (25°C) |
| Acidity (pKa) | 5.6 |
| Basicity (pKb) | pKb = 5.8 |
| Magnetic susceptibility (χ) | -64.0e-6 cm^3/mol |
| Refractive index (nD) | 1.333 |
| Viscosity | Viscosity: 2.08 cP (25°C) |
| Dipole moment | 3.59 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 309.7 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -199.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3217.6 kJ/mol |
| Pharmacology | |
| ATC code | D08AJ68 |
| Hazards | |
| Main hazards | May cause an allergic skin reaction; harmful if inhaled; causes serious eye irritation; toxic to aquatic life with long lasting effects. |
| GHS labelling | GHS02, GHS05, GHS07, GHS08 |
| Pictograms | GHS05,GHS07 |
| Signal word | Warning |
| Hazard statements | H302, H315, H317, H319, H400, H410 |
| Precautionary statements | P261, P273, P280, P302+P352, P305+P351+P338, P333+P313, P337+P313, P362+P364 |
| NFPA 704 (fire diamond) | 3-0-0 |
| Flash point | 93.9 °C |
| Autoignition temperature | 400°C |
| Lethal dose or concentration | LD50 oral rat 53 mg/kg |
| LD50 (median dose) | LD50 (median dose): Rat oral 50 mg/kg |
| NIOSH | WA 7125000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.001% |
| Attribute | Manufacturing Commentary |
|---|---|
| Product Name & IUPAC Name |
Methylisothiazolinone 2-methyl-4-isothiazolin-3-one Naming in production facilities adheres to IUPAC standards to maintain clarity within technical documentation and regulatory filings. |
| Chemical Formula |
C4H5NOS The empirical formula serves as a reference point throughout material balance calculations during batch synthesis and quality verification. |
| Synonyms & Trade Names |
MIT, MI, Methylisothiazolone, 2-Methyl-2H-isothiazol-3-one Manufacturing lots are referenced by multiple names on internal tank labels and process control software to prevent confusion, as incoming inquiries, supplier documents, and customer requirements rarely use a single standardized term. |
| HS Code & Customs Classification |
29349990 (under “Other heterocyclic compounds”) In chemical export operations, the precise HS code has been verified across customs authorities and shipping regions. Classification accuracy makes a direct impact on the clearance speed, documentation requirements, and declarations, especially due to mixture import restrictions and variable regional regulation of isothiazolinone derivatives. |
Methylisothiazolinone (MIT) occupies a specialized position within the biocide production segment, with a product identity footprint that extends across global regulatory and customer ecosystems. Facility batch tickets must specify the IUPAC name for traceability during compliance audits, but sales teams and clients most commonly request MIT or isothiazolinone on practical purchase orders. Internal process control lists always correlate synonyms and abbreviations to ensure there are no errors in drum or IBC content identification, avoiding mix-ups during intermediate transfers or finished goods staging.
Chemical formula tracking is practical beyond theoretical reference; it forms the backbone of stoichiometry-driven batch correction if raw material lots drift from nominal purity. In QC testing, C4H5NOS signals the target compound but actual outcome depends on process route and impurity suppression strategy. Byproduct and unreacted precursor identification are always compared back to the theoretical parent structure for each batch.
The HS code 29349990 is commonly utilized. In practice, customs brokers frequently request supporting documentation to verify the absence of other functional groups or co-preservatives in blended actives, since misclassification at the port of entry can hold up perfectly specifications-compliant shipments. Technical staff frequently handle inquiries relating to the split between pure MIT and MIT/CMIT blends, as regulatory nuances in some regions impact allowable concentrations and the need for additional documentation, especially for end-user applications in personal care or water treatment. Internal export documentation structure always separates single-active and mixture codes to align with routine customs control points and reduce error risks during large-scale shipments.
Commercial methylisothiazolinone (MIT) appears as a colorless to pale yellow liquid in concentrated aqueous solution, developing a faint, characteristic odor. Solid forms exist at high purity or low temperature but are rarely encountered in production-scale handling. Observed color and clarity vary depending on product grade and degree of dilution—technical grades may show more yellow tinge if processed with higher impurity tolerance or less advanced purification. Formulators prefer clear, colorless solution for use in applications such as cosmetics or high-purity industrial processes.
Melting and boiling points are strongly concentration-dependent as neat methylisothiazolinone is rarely isolated at scale. Manufacturers preparing the product as a stabilized solution avoid direct handling of pure substance and instead monitor pH, solution strength, and visible clarity during packaging. Density also follows solution strength; downstream users requiring precise density measurements must request batch-specific data.
Stability depends on solution composition and storage conditions. Acidic pH and stabilization agents extend shelf life, suppressing decomposition pathways such as hydrolysis and oxidative breakdown. Higher temperatures, alkaline pH, or exposure to certain metals can trigger loss of active content and darkening of solution. Storage in inert containers and maintaining neutral to slightly acidic pH reduces risk of unwanted reactivity.
Methylisothiazolinone dissolves readily in water and, at relevant use concentrations, produces a clear aqueous solution. Organic solvent solubility is limited and relevant primarily for specialized formulation work in paints or other solvent-borne systems. Laboratories preparing dosing solutions for QC or customer simulation ensure pH is adjusted promptly and excess heating is avoided to prevent decomposition.
Specification requirements for MIT depend on intended application. Cosmetic and personal care use typically calls for high purity, controlled residual solvents, and stringent limits on formaldehyde. Technical grades for industrial biocides tolerate higher impurity content. Exact values for active content, pH, formaldehyde, and color may be set by customer or regional regulatory requirements and are batch-certified before release.
Main impurities include isothiazolinone homologues, trace formaldehyde, chloride ions, and residual unreacted starting materials. Content of each depends on selected synthesis route, purification efficiency, and potential cross-contamination during production. Purification processes are routinely upgraded to push these impurities below regional regulatory thresholds, especially for cosmetic and household use.
Active content and impurity limits are usually determined by titration, HPLC/UV analysis, and sometimes colorimetric methods. In-house methods are validated against recognized standards where available. Analytical process selection is based on detection sensitivity, matrix complexity, and regulatory demand for result traceability.
Key raw materials involve a starting isothiazolone precursor, methylamine or a suitable methyl donor, and oxidizing agents. Source selection is dictated by cost, impurity profile, and supply chain reliability. Certain mineral acids or specific stabilizers are used to control polymerization or degradation during manufacture and storage.
Industrial synthesis follows nucleophilic substitution and oxidation reactions under aqueous conditions. The process proceeds through chlorinated intermediates, methylation, and controlled oxidation. Selection of pathway depends on target impurity profile and ease of downstream purification.
Reaction temperature, reagent addition rates, and pH are tightly controlled to avoid over-oxidation, by-product formation, or loss of yield. Continuous monitoring limits batch-to-batch variation and ensures consistency. Purification often consists of aqueous extraction, phase separation, carbon treatment, and vacuum stripping—steps prioritized based on product end-use and local discharge limits for waste streams.
Each batch is sampled by production QC technicians, tested for active MIT content, impurity levels, and solution properties. Batches out of specification are subject to reprocessing or downgrade assignment. Release criteria are regularly re-evaluated based on customer feedback and regulatory changes. Customer-specific certificates of analysis can be provided upon request.
Methylisothiazolinone exhibits biocidal activity based on electrophilic reactivity with nucleophilic groups in proteins. In industrial settings, it does not undergo further transformation without extreme conditions.
Catalysts are not typically required beyond pH control, and most downstream modifications rely on dilution or blend-based formulation rather than chemical derivatization. Excessive heat, strong alkali, or electrophiles trigger decomposition.
MIT can be blended with other isothiazolinones (such as CMIT) for broad-spectrum preservative formulations. Seldom is it directly converted to new molecules on the user’s site—most downstream activity focuses on formulating into products such as paints, cleaning agents, and personal care items.
Industry-standard practice holds MIT in cool, shaded areas, with constant monitoring to protect from temperature swings, UV exposure, and excess air ingress. Drums and totes are selected for compatibility—typically HDPE or lined metal—to avoid catalytic breakdown or tin contamination. Humidity control is critical for bulk storage of aqueous solutions to mitigate microbial growth and slow hydrolysis rates.
Contact with metals, especially iron or copper alloys, is avoided. HDPE, fluoropolymer-lined, or glass-lined vessels offer sufficient protection. Bulk users frequently flush lines and fittings before introducing new batches to minimize cross-reaction risk and product darkening.
Shelf life is defined according to grade, solution pH, and stabilizer addition. Key signs of degradation include darkening, unexpected odor, or precipitate formation. Formulators screen for active MIT loss by chemical assay prior to use in regulated applications such as cosmetics, where shelf life enforcement is stricter.
Methylisothiazolinone carries classifications for skin sensitization and acute aquatic hazard. Labeling requirements are set by global (GHS/CLP) or region-specific systems, and must be reflected in all shipping and handling documents. Hazard codes reflect concentration, so diluted blends may differ from neat solutions.
Skin contact, inhalation of vapors, or accidental ingestion present both acute and chronic toxicity risks. Manufacturing workers are trained to avoid direct contact, and closed systems are preferred to keep vapor concentrations below regulatory thresholds.
Toxicology studies identify thresholds for skin and eye sensitization, and industries handling MIT define workplace exposure strategies around these findings. Detailed exposure limits and toxicity values are assigned through regional regulation, with periodic updates as new risk data becomes available. Production facilities install extraction ventilation and require gloves, goggles, and protective clothing for all handling and maintenance operations.
Production scale depends on both intended market—cosmetic, industrial, or biocide—and the compliance burden in destination countries. Increased restrictions in the EU have driven more conversion to high-purity cosmetic grades, while technical grade capacity remains stable for industrial biocide markets. Output rates are set by reactor size, batch length, and the purification load required for each specification.
Lead time hinges on scheduled campaigns and the grade complexity. Cosmetic and pharmaceutical grades require longer lead times due to more stringent purification and QC. Technical grade can be offered with shorter notice given less demanding impurity control. Typical MOQ varies by packaging: drum or IBC, with bulk ISO tank supply available on a contract basis.
Packaging is dictated by both regulatory and industrial hygiene demands. IBCs and steel drums are standard for bulk transportation of industrial grade. For higher compliance markets, HDPE containers with tamper-evident seals are used. Custom pack sizes for pilot, sampling, and small-batch use can be supplied subject to agreement and risk assessment for cross-contamination.
Shipments of methylisothiazolinone face restrictions in certain markets due to labelling requirements and transport hazard assessments. Contract customers prefer FOB or CFR terms, while spot cargoes often move on EXW or FCA basis. Payment terms are set based on historical risk evaluation, customer location, and order recurrence. Letter of credit or advance payment is standard for new accounts.
Raw material input accounts for over half the product cost. Major contributors are the supply of methylamine and chlorine derivatives. Variations in global methylamine pricing, caused by energy price changes and feedstock allocation, drive cost fluctuation. Batch-to-batch purification costs increase as product grade demands stricter purity, particularly for leave-on cosmetic applications where ICMAD and SCCS guidelines apply.
Price differentiation reflects more than just analytical purity. Certified grades command higher price due to validated absence of sensitizing impurities, audit trails, and full documentation support. Packaging for contact-sensitive or pharmaceutical grades adds to delivered cost due to GMP traceability and specialized handling.
Upstream volatility stems from global demand spikes in the chemical supply chain, feedstock allocation swings, and plant maintenance cycles. Disruptions in ammonia and chlorine supply lines, especially during shutdown seasons, have a cascading effect. Environmental compliance upgrades at primary cracker plants also add cost through tighter emissions limits.
Grade-specific pricing reflects the depth of purification and QC. Technical grade, with relaxed impurity ceilings, aligns with industrial demand for microbiological control. Certified grades require validated test reports for restricted contaminants and can carry batch-specific traceability, pushing price higher. Specialized lot releases, especially those produced under GMP or equivalent process environments, serve niches where both end-use auditability and regulatory compliance are critical.
Methylisothiazolinone supply shows regional fragmentation, shaped by compliance-driven demand and local regulatory limits. North America and Southeast Asia retain strong demand for technical grades in water treatment and coatings. The EU's restriction on leave-on cosmetic use shifts bulk demand to rinse-off applications requiring lower active concentration.
US buyers favor contract supply with established manufacturers to ensure traceability and compliance with FDA guidelines. The EU market is tightly regulated under REACH, with supply dominated by a small pool of certified producers. In Japan, ongoing regulatory review and local approval cycles constrain imported material flow. Indian and Chinese buyers prioritize cost control, but migration toward higher grades reflects increasing exports of formulated products to regulated markets.
Long-term price movement depends on raw material volatility and downstream regulatory adaptation. Lower demand in the EU for leave-on applications suppresses high-purity consumption, while technical and specialty niche grades remain stable or grow slowly. Expected tightening of environmental requirements, coupled with sustained raw material volatility, points to a moderate increase in average pricing through 2026, especially in markets where documentation and traceability standards exceed basic analytical threshold compliance.
Analysis draws on internal batch production data, regional feedstock and spot purchase records, regulatory filings, and published procurement feedback from major downstream users. Any projected trends are validated using multi-year contract averages and not single-supplier spot prices.
Rising scrutiny of sensitization potential, especially in personal care segments, has prompted downstream users to reformulate or reduce usage concentrations. The global move to digitalize supply chain documentation results in more transparent origin and lifecycle records. Recent years have also seen regional production adjustments to accommodate evolving restrictions in the EU and North America.
Regulators in the EU continue to drive tighter controls, focusing on cumulative exposure in consumer goods. New documentation requirements now demand batch-level declaration of trace impurities. Egypt, South Korea, and Brazil have announced their intention to align national restrictions more closely to EU SCCS statements, influencing global supply allocation priorities.
Producers have invested in improved purification steps, advanced analytical controls, and increased traceability across finished batches. Multi-site qualification and process harmonization between Asian and Western plants help buffer regional supply shocks. Engagement in industry working groups shapes both product stewardship and the technical rationale for future standard updates. Contract formulations increasingly include negotiation terms for both analytical profile and documentation support rather than technical parameters alone.
Methylisothiazolinone, produced in various grades, finds use across multiple industrial sectors. The primary industries include water-based coatings, adhesives, polymer emulsions, detergents, household cleaners, personal care products, oilfield chemicals, and pulp and paper. Each of these fields imposes distinct performance and impurity control expectations on the product.
| Industry | Typical Product Grade | Key Industrial Focus |
|---|---|---|
| Paints, Coatings, Adhesives | Technical or Industrial Grade | Microbial control; Residual impurity profile; Compatibility with formulation ingredients |
| Household Cleaning | Technical, Home Care Grade | Preservation efficacy; Odor neutrality; Stabilizer compatibility |
| Personal Care & Cosmetics | Cosmetic or High-Purity Grade | Ultra-low impurities; Strict absence of chlorinated byproducts; Allergen profile |
| Pulp & Paper, Water Treatment | Process/Industrial Grade | Cost efficiency; Volume stability; Control of mineral contaminants |
| Oilfield Chemicals | Technical/Custom Grade | Thermal stability; Compatibilities with hydrocarbon fluids; Batch-to-batch reproducibility |
Start from the intended end-use. Industrial bulk applications, consumer product manufacturing, and high-purity personal care products each prioritize different product characteristics. Paint and coating manufacturers often accept industrial grades, focusing on antimicrobial efficacy and cost. Personal care formulators select high-purity, low-residual grades to satisfy user safety and labeling obligations.
For regulated applications (cosmetics, household cleaners, water treatment), regional regulations (EU, US, China, etc.) and customer-specific requirements dictate allowable maximums for impurities, allergenic potential, and authorized ingredient lists. Confirm both local and end-market compliance before selecting grade, as analysis for region-specific banned substances is sometimes required batch-by-batch.
Batch impurity levels shift with raw material quality, synthesis route, and post-reaction treatment. For sensitive markets, product release depends on targeted analysis (typically GC, HPLC) of residual impurities and byproduct classes. Cosmetic or pharma-adjacent use benefits from analytical traceability to benchmarked technical standards. Industrial applications usually relax impurity restrictions, provided downstream processes tolerate trace contaminants.
Large-scale manufacturing shifts focus to process consistency and long-term supply reliability. Higher purity grades involve extra purification stages and closer process monitoring, raising unit cost. Where formulation tolerance is higher for technical grade product, cost advantages result from fewer purification steps and relaxed release criteria.
Formulation and in-process compatibility require real-world validation. Sampling enables direct assessment of batch stability, color, odor, and preservative performance in customer-specific matrices. QC and production teams typically recommend multi-batch qualification to confirm consistency before scale-up, especially for regulated or high-purity sectors. The final release standard references both internal quality control benchmarks and mutually agreed customer requirements.
From a manufacturer's perspective, implementing recognized quality management systems forms the backbone of production assurance for Methylisothiazolinone. Facilities operate under certified quality frameworks such as ISO 9001 for management processes, with systematic internal reviews tied to raw material traceability, batch documentation, and deviation investigations. Regular audits validate control over cleaning protocols, supplier qualification, and preventative maintenance throughout the plant. An experienced manufacturing team reviews and adapts quality management measures as industry standards progress or as requirements shift between industrial and personal care sectors. Certification status always reflects the actual scope of manufacturing and the specific unit handling Methylisothiazolinone production.
Industry use of Methylisothiazolinone transitions between different application grades, influenced by end-market requirements. For applications in cosmetics, customers typically request evidence of compliance with global regulations such as EU Annex V (Cosmetics Regulation) or US EPA listings for biocides. Certification of certain grades may extend to compliance declarations for allergen content, purity requirements, or absence of specified impurities depending on the regulatory region or sector. Documentation confirming these specifications is readily issued based on batch-tested data and validated through manufacturer-run, traceable analytical methods.
Every shipment of Methylisothiazolinone includes full-origin Certificates of Analysis and, where required, Statements of Compliance tailored to the regulations or standards governing intended use. Technical dossiers, analytical method protocols, and historical batch consistency records can be provided to support safety assessments or new product registrations. For customers in regulatory submission processes or those with tailored specification needs, manufacturing personnel can facilitate deeper dossier access or generate additional technical clarification based on in-plant analytical records, source traceability, and documented deviation closures.
Supplying Methylisothiazolinone at scale requires a robust balance between continuous reactor operation and strict schedule alignment with downstream finishing and packaging. Production capacity is matched with demand forecasts, supply chain contingencies, and inventory buffer policies. Experience shows that for customers managing variable seasonal demand or market shifts, flexibility in order volumes, delivery frequencies, and call-off order logistics provides significant risk mitigation. Clients can enter into rolling forecast supply contracts, long-term agreements, or ad hoc purchasing arrangements depending on their planning horizon and warehouse capacity.
In typical manufacturing practice, production stability depends on raw material lead times, purification step yields, and the extent of process automation. Control points across critical synthesis stages ensure minimization of byproduct formation and in-batch variability. Process integration, from raw material weighing to reaction endpoint through to in-line filtration and packaging, reduces external contamination risk and batch-to-batch deviation. For customers requiring uninterrupted flow in large-scale downstream processes, priority supply capabilities and dedicated batch allocation options are available, subject to mutual scheduling agreement.
Sample requests for Methylisothiazolinone are received and evaluated based on specified grade, intended application, and customer-specific test or validation requirements. Technical service teams coordinate with production supervisors to select representative lots from current campaign output, ensuring traceability to full-scale batch documentation. All samples ship with corresponding Certificates of Analysis and may include additional technical support for application-specific formulation or compatibility testing protocols. Special requests regarding sample pack sizes or handling conditions can be discussed directly with the production support group.
Flexibility in cooperation mode adapts to customer operational realities. Options include minimum order quantity adjustments, split deliveries for multi-location fulfillment, or buffer stock arrangements for critical supply security. Manufacturing planners coordinate closely with commercial managers to build contingency into production schedules, including multi-plant allocation potential if supply risk escalates. Transparent communication, combined with real-time production progress reporting, allows customers to adjust requirements and logistics even as market conditions fluctuate. Direct dialogue with technical and quality managers ensures rapid resolution of specification questions, urgent shipment needs, or process adaptation discussions.
| Aspect | Manufacturer Practice |
|---|---|
| Quality Management | Certified systems (e.g., ISO 9001), documented process controls, regular audits |
| Product Certifications | Grade- and application-dependent; declarations for regulatory, allergen, impurity specs when required |
| Supply Flexibility | Rolling forecasts, contract supply, ad hoc spot availability, split delivery options |
| Sample Provision | Supported by production traceability, accompanied by technical support and documentation |
| Cooperation Modes | Adapt to customer logistics, demand variability, and risk management requirements |
Across the preservative sector, methylisothiazolinone (MIT) faces constant scrutiny due to regulatory changes and end-user safety demands. Teams focus on reducing allergenic potential through process tweaking, as excessive minor impurity build-up during synthesis can usually intensify downstream regulatory hurdles. Projects seek to lower formaldehyde-releasing impurities, rationalize the raw material feed ratios, and develop reactor conditions that yield reliable assay levels without amplifying byproducts. Rapid micro-analysis of trace contaminants has become standard in QC rooms, and R&D crews regularly exchange findings with formulation chemists driving compatibility tests in new cosmetic or detergent bases.
Methylisothiazolinone's scope continues to move into alternatives for short-term preservation in water-based construction materials, selected adhesives, and crop protection tanks, due to its efficacy under high-dilution stress. Shifts in regional demand come from countries tightening parabens or longer chain isothiazolinones, which prompts technical support teams to re-validate existing MIT grades in new matrices. Some industrial end-users have started requesting MIT grades customized for reduced odor, a trend led by clients producing sensitive building adhesives and inks.
Industrially, achieving narrow impurity profiles while maintaining throughput has posed the chief challenge. Most process improvements involve better reactor temperature ramp management and real-time spectroscopic checks for side-reaction suppression—critical to avoid unwanted byproducts that negatively affect formulation compatibility. The main breakthrough has come from fine-tuning the balance between oxidation and amination rates in intermediate steps, allowing tighter grade targeting for ultra-low-impurity applications. Another critical issue lies in the compatibility with modern surfactant blends, as certain surfactants seem to react with trace acidic byproducts, causing instability in finished formulations. This has triggered sustained support for customers running pilot blending trials.
Customer engagement indicates the MIT market will likely experience stable to slightly growing demand in sectors that have not faced blanket restrictions. New specialty adhesive lines, paints, and agricultural auxiliary products are core areas where demand persists, provided technical support can guarantee batch regularity and traceability for sensitive downstream validation. Legislative review cycles and retail labeling pressure in developed regions may constrain cosmetic use, but regions with stricter microbial control regulations create openings for higher-grade MIT supply. Allocation of R&D resources often shifts in response to the legal environment, especially where allowable usage levels keep changing.
Process lines are moving toward tighter in-line analytics and automated dosing to minimize raw material carryover. Modular reaction systems, designed for quick changeovers, are preferred in manufacturing plants serving diverse application channels. Manufacturers with in-house purification towers are best positioned to deliver grade-specific MIT, as customers request documentation about impurity origins and removal strategies. Automated analyzers and continuous impurity mapping during synthesis support tighter release standards, especially for customers in biocidal formulations where active residue monitoring forms part of regulatory compliance.
MIT production generates aqueous effluents and vapor-phase chlorinated side products, requiring thorough abatement and recycling. Plants that have invested in closed-loop solvent recovery and condensate stripping show better cost control and reduced environmental loading. Sourcing of raw amines and starting isothiazolone intermediates has moved toward suppliers compliant with regional green chemistry standards. Customers increasingly ask for documentation on effluent minimization and potential for use of recycled solvents. Requests for biodegradable derivative blends have prompted feasibility studies in specialty application lines, but technical team experience shows that pure MIT grades remain challenging to further biodegrade within the limits of commercial preservative dosing.
Manufacturing technical staff maintain direct communication with customers, supporting application-specific troubleshooting and advising on grade selection based on batch impurity fingerprint, end-use stability needs, and regulatory status in the user’s jurisdiction. Queries about compatibility with new surfactant or polymer systems are forwarded to R&D chemists for joint product stability testing. Where downstream processing or storage leads to unexpected crystallization or color drift, technical specialists review both plant and customer-side storage conditions and supply chain routes, helping verify where the property deviation first arises.
Application trials often begin with small pilot batches mixed at the customer's facility, observed over defined time frames for any microbial load breakthrough or formulation instability. Feedback loops between customer tech teams and plant QC labs allow batch-specific advice on dosing, pre-mix procedures, and tank cleaning protocol to minimize MIT degradation or loss to matrix binding. Certain industries, such as adhesives or polymer dispersions, often require modifications in MIT addition points, with technical support reviewing batch records to recommend stage-of-formulation adjustments. For users with custom regulatory or sensory requirements, engineers provide advice on alternate MIT concentrations or blending strategies based on real-life production runs.
The manufacturer's after-sales policy covers continued technical documentation provision, root-cause investigation in case of field complaints, and recurring training for customer quality auditors. Internal quality assurance protocols match shipment samples with in-process retention samples for any claim review. Product traceability is guaranteed through batch-locked documentation and supply chain audit logs, with reasonable review timelines in line with plant records. Storage and transport support comes with practical recommendations derived from years of handling experience under varying climate and container conditions, not from generic shelf-life tables.
Our facility produces methylisothiazolinone by adhering to defined synthesis routes and in-process controls. Every step, from raw material intake to distillation and finishing, operates under documented process parameters. Skilled operators monitor every batch and rely on calibrated instruments. This approach allows production runs to repeatedly achieve narrow specification ranges for purity, active content, and pH. Yearly external audits and regular internal reviews ensure our factory maintains robust quality stewardship throughout.
Customers in coatings, adhesives, and water-based formulation sectors rely on our methylisothiazolinone. Paint and emulsion producers incorporate it to safeguard against microbial fouling in production, storage, and end-use. Premix and finished product manufacturers in adhesives specify our material to help maintain stability and shelf life. Household, industrial, and institutional cleaners use it to meet microbial control requirements. The preservation system’s performance and predictability depend on consistency from production to packaging—an area where plant-level manufacturing control adds direct value for downstream operators.
Focus on process control extends beyond core reaction stages. Materials are tested at multiple checkpoints in our on-site laboratories, which operate with validated methods and traceable reference standards. Every dispatch includes supporting analytical data and batch-specific test results. Production data informs process improvements, not just compliance protocols. This results in supply batches that align tightly to buyer targets and reduces the frequency of deviations in their lines.
We handle methylisothiazolinone packaging in a facility equipped for liquid chemical processing and filling. Various drum and container options accommodate both regional clients and international shipments. Filling lines operate under closed transfer systems, minimizing contamination and ensuring consistent fill weights. Inventory turnover rates and packaging configurations are driven by actual client demand and forecasting, enabling us to supply high volumes on scheduled intervals as well as respond to custom shipment requirements.
Our technical team consults directly with manufacturing engineers and formulators, interpreting process feedback and supporting application scale-ups. Assistance may extend to evaluation in customer labs, troubleshooting preservation performance, or offering advice on regulatory and labelling compliance. We field in-plant questions rapidly and document findings for repeatable solutions. This service support comes from direct factory knowledge backed by production history, data logs, and staff know-how—not relayed messaging from intermediaries.
Our operational control over the complete methylisothiazolinone manufacturing cycle has a real business impact for industrial buyers. Production planners and procurement teams benefit from reliable lead times and technical transparency. Routine technical discussions between our team and client operators reduce process uncertainties and keep lines running to schedule. By providing traceable quality documentation and responsive logistics, downstream manufacturers cut the risk of unplanned formulation changes and inventory disruptions. The combination of technical access, supply consistency, and dedicated packaging formats supports cost control and process reliability for operators across manufacturing, blending, and distribution sectors.
Methylisothiazolinone stands as one of the most consistent preservatives for water-based systems across industrial and consumer applications. We have been synthesizing this material at commercial scale for over a decade, working both with stand-alone MIT and with carefully balanced blends when required. This persistent engagement with real-world formulation challenges gives our team first-hand knowledge of its performance envelope, limitations, and regulatory environment.
The bulk of our clients working in paints, personal care, home care, and similar product categories rely on concentrations of methylisothiazolinone between 50 and 100 ppm. Global regulations help define these practical usage levels; the EU restricts standalone MIT in leave-on cosmetics and limits rinse-off applications to 0.0015 percent, equal to 15 ppm. Technical testing shows effective microbial control in water-based matrices often begins at 25 ppm; many commercial products balance cost concerns with efficacy by holding totals close to 100 ppm, within legal constraints.
Overdosing methylisothiazolinone does not translate to better preservation and often creates unwanted side effects, such as skin irritation or loss of compliance. Extensive internal shelf-life studies confirm microbiological efficacy plateaus above recommended application rates. Factoring in typical storage and distribution hurdles further underlines the need for accurate dosing and transparent ingredient tracking. Our technical specialists frequently support clients with in-lab dosing trials to define the minimum viable concentration, reducing raw material consumption without undermining control of bacteria and fungi.
Stability continues as a pivotal focus in our own QC regime. In isolation, methylisothiazolinone remains chemically robust under controlled storage — standard practice keeps it in dark, cool conditions, away from strong oxidizers and reducing agents. Most aqueous matrices support this stability provided pH sits between 4 and 8. Above pH 9, breakdown accelerates, compromising the protective function and undermining final product shelf life.
Temperature also drives stability outcomes. Elevated temperatures push the degradation rate higher, especially in alkaline environments. Our QA data finds little measurable loss in cold storage or at ambient conditions over a typical two-year inventory cycle. Thermally stressed formulations (long-term above 40°C) invite faster breakdown, so packaging and logistics require engineering with storage realities in mind.
We trace preservative loading throughout the entire blending operation. Routine micro-challenge testing benchmarks performance beyond chemical assay, ensuring that real-world biocidal behavior matches stated content by the time finished products reach the warehouse. Shelf-life projections derive from long-term internal stability studies, full micro-screening, and compositional analysis after simulated storage extremes.
Our approach focuses on lot-to-lot consistency and proactive technical support. We offer custom package sizes, rapid shipment from onsite inventory, and transparent COA with every order. Our in-house R&D team monitors evolving regulatory changes and proactively adapts our grade recommendations. When new stability variables or process changes arise, our scientists collaborate directly with end users to troubleshoot pH or heat-driven shifts.
By controlling the complete manufacturing process — from raw material procurement to final QC release — we provide in-depth support for every facet of methylisothiazolinone usage in demanding aqueous systems, protecting both product quality and regulatory standing year after year.
As the original manufacturer of methylisothiazolinone, we understand that commercial buyers are focused on pinning down the right minimum order quantities and honest lead times before planning a bulk purchase. Experience from years of supplying various industries—personal care, paints, adhesives, and beyond—shapes how we determine production scheduling and delivery promises for this particular biocide.
Our production lines and raw material sourcing operate at industrial scale. This means the lowest practical order quantity for bulk methylisothiazolinone usually starts at one standard drum—200 kilograms net content. Clients running medium to large manufacturing plants often request multiple drums or palletized loads, which slot straight into our regular dispatch flows. Containerized volumes beginning at 10 metric tons are also common for regional hubs and OEM-level blenders, and economies of scale on packing and logistics kick in at those volumes.
Each batch comes off the reactor with consistency our customers rely on. At lower volumes or frequent small orders, the overhead in sampling, analysis, and packaging is disproportionately high—not just for us but for any direct producer operating modern chemical sites. This structure allows us to put resources where they matter most: quality, process stability, real-time compliance checks, and full traceability.
Standard lead times for shipping bulk methylisothiazolinone start at 2 to 3 weeks from order confirmation to loading at our plant. Certain periods—seasonal spikes, holiday closures, or substantial upticks in global demand—may add several days to this window, but we forecast and flag such issues in advance thanks to an experienced operations team. Repeat clients who work with annual or semi-annual contracts benefit from block-reserved production slots, which is an effective way to buffer against market volatility and logistics congestion.
In situations requiring customized grades or specific concentrations—some markets want methylisothiazolinone at different percentages, or packaged in intermediate bulk containers versus drums—the lead time will adjust slightly. This is not a guessing game; our technical and logistics teams review each order against tank schedules, fill line workloads, and regulatory paperwork to deliver accurate timelines. We take on the risk of raw material price swings and freight rate shifts, so customers can focus on integrating the product into their own production with less uncertainty.
Methylisothiazolinone is regulated in most global markets, with clear controls on purity, labeling, and traceability. To keep each batch compliant, no steps are skipped in the testing and certification process. Ordering below the practical minimum would only open the door to mixing of lots and uncontrolled variation. That's why our thresholds exist: to keep control, batch after batch.
For customers facing challenging timelines or needing support on documentation, including REACH or other regional regulatory paperwork, we provide direct technical assistance. Early engagement with our team always yields the best results. Realistic timelines, transparent batch tracking, and the ability to scale up on short notice—all come from controlling the entire process at the factory level, not through intermediaries.
Shipping methylisothiazolinone (MIT) involves more than loading drums onto a truck or stuffing containers. On the manufacturing floor, our handling process must match the high standards set by global regulators. We fill every drum with strong awareness of chemical hazards. This preservative earns classification as a hazardous substance under both maritime IMDG and air IATA guidelines. A slip-up in packaging or mislabeling sets off delays, fines, and safety risks—experience teaches us quick shortcuts undermine trust and quality.
Our labels do not exist just for decoration or inventory control. Each container leaves our plant with GHS-compliant labeling, including signal word, hazard pictograms, and complete chemical identification. Accurate UN number (UN 3082 for liquid MIT in many cases), hazard class, and appropriate shipping name mark out every drum. Our print system and staff training ensure this information stays legible and accurate, never smudged or skipped.
Chemical export means paperwork—lots of it. As original producers, we issue safety data sheets (SDS) specific to each batch. These documents explain medical, environmental, and spill control information in detail. Our logistics team compiles the Dangerous Goods Declaration, matching each batch’s volume and hazard classification to its shipping route. Air and sea carriers enforce these details fiercely; a missing line or wrong hazard code results in shipment rejection.
Based on direct handling, methylisothiazolinone corrodes skin and carries acute aquatic toxicity. Such risks drive us to rely on high-density polyethylene drums or IBCs with secure, tamper-proof seals. We select tight-head drums for volumes under a metric ton and sturdy intermediate bulk containers for large industrial orders. Every closure mechanism undergoes quality checking so accidental leaks do not expose workers or handlers.
We maintain a team trained extensively in chemical logistics. Loading staff follow internal checklists before authorizing dispatch—drums double-checked for the correct label orientation, packaging integrity, and compliance paperwork inclusion. Our export office stays updated on ever-changing international rules, scanning databases for regulatory amendments and updating workflow. By holding regular drills and retraining sessions, we keep the system reliable and responsive, regardless of destination.
Incidents with preservatives rarely stay contained. A mislabeled drum or incomplete paperwork jeopardizes several links in the supply chain, starting from our plant right up to the end user. Our direct experience shows robust adherence to transport codes is not a bureaucratic box-tick but a protection of people, property, and reputation. To prevent costly interruptions, every package, pallet, and container leaving our facility aligns fully with the law and industry best practices. Every member of our team knows the seriousness of the responsibility and works to deliver methylisothiazolinone safely, with complete legal backing and peace of mind.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
